Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Uncertainty-Aware Evidential Multi-Modal Fusion Network for Large-Scale Multi-Center Major Depressive Disorder Classification.
Journal: IEEE transactions on bio-medical engineering
Published: April 23, 2026
Multi-Scale Convolutional Attention Enhanced Residual Network for Cuff-less Blood Pressure Prediction.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025
Hierarchical Multi-Scale Feature Fusion Network for Multi-Center Major Depressive Disorder Classification with T1-weighted MRI.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists.
Journal: Journal of medicinal chemistry
Published: May 28, 2025
Human Eye Activity Monitoring Using Continuous Wave Doppler Radar: A Feasibility Study.
Journal: IEEE transactions on biomedical circuits and systems
Published: October 18, 2023
AutoMLP: A Framework for the Acceleration of Multi-Layer Perceptron Models on FPGAs for Real-Time Atrial Fibrillation Disease Detection.
Journal: IEEE transactions on biomedical circuits and systems
Published: July 26, 2023
Regioselective synthesis of N1-substituted-4-nitropyrazole-5-carboxylates via the cyclocondensation of ethyl 4-(dimethylamino)-3-nitro-2-oxobut-3-enoate with substituted hydrazines.
Journal: Organic & biomolecular chemistry
Published: November 29, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4.
Journal: Journal of medicinal chemistry
Published: June 22, 2022
Discovery of (S)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain.
Journal: Journal of medicinal chemistry
Published: March 08, 2022
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases.
Journal: Journal of medicinal chemistry
Published: October 28, 2021
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design.
Journal: Journal of medicinal chemistry
Published: September 20, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.
Journal: Journal of medicinal chemistry
Published: September 08, 2021
Last Updated: 09/26/2026